Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Releases Final Guidance On External Clinical Study Monitors

This article was originally published in The Gray Sheet

Executive Summary

Final guidance issued by FDA March 28 acknowledges device company concerns about the burden of clinical trial data monitoring committees, but stops short of acquiescing to requests to substantially change its 2001 draft recommendations

You may also be interested in...



Data Monitoring Should Be Tailored To Device Trial Needs – Manufacturers

FDA's guidance on clinical trial data monitoring committees (DMCs) should make clear that device firms need not hire independent statisticians to perform interim analyses, Medtronic writes in Feb. 15 comments to FDA regarding the November 2001 draft guidance

Data Monitoring Committees Are Useful For High-Risk Phase I/II Trials – FDA

FDA strongly recommends data monitoring committees for early-phase clinical trials where the investigator is also the sponsor, or where subjects may be placed at unusual risk, a Nov. 16 draft guidance on DMCs states

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

UsernamePublicRestriction

Register

MT023392

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel